谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.

Patient-reported Outcomes in Relapsed/refractory Multiple Myeloma Treated with Melflufen Plus Dexamethasone: Analyses from the Phase II HORIZON Study

Alessandra Larocca,Xavier Leleu,Cyrille Touzeau,Joan Blade,Agne Paner,Maria-Victoria Mateos,Michele Cavo,Christopher Maisel,Adrian Alegre,Albert Oriol,Anastasios Raptis,Paula Rodriguez-Otero,Amitabha Mazumder,Jacob Laubach,Omar Nadeem,Anna Sandberg,Marie Orre, Anna Torrang,Nicolaas A. Bakker,Paul G. Richardson

British Journal of Haematology（2021）

引用 4|浏览61
暂无评分
关键词
patient-reported outcomes,melflufen,melphalan flufenamide,health-related quality of life,relapsed,refractory multiple myeloma
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要